Hongxiang Hui

Summary

Publications

  1. ncbi Hypoglycemic herbs and their action mechanisms
    Hongxiang Hui
    Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, 90073, USA
    Chin Med 4:11. 2009
  2. ncbi Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways
    Hongxiang Hui
    UCLA Center of Excellence in Pancreatic Disease, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024 7073, USA
    Pancreas 39:315-22. 2010
  3. ncbi The role of GLP-1 in the regulation of islet cell mass
    Angela Bulotta
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Cell Biochem Biophys 40:65-78. 2004
  4. ncbi Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes
    Hongxiang Hui
    Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA
    Diabetes Metab Res Rev 21:313-31. 2005
  5. ncbi Direct spectrophotometric determination of serum fructose in pancreatic cancer patients
    Hongxiang Hui
    Division of Endocrinology, David Geffen School of Medicine at UCLA, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, CA 90024, USA
    Pancreas 38:706-12. 2009
  6. ncbi Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs
    Eugenio D'Amico
    Division of Endocrinology, Cedars Sinai Medical Center, Los Angeles, California, USA
    J Mol Endocrinol 34:377-90. 2005
  7. ncbi Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats
    Takeshi Aoki
    Surgical Research, Department of Surgery, Cedars-Sinai Medical Center, David Geffen UCLA School of Medicine, Los Angeles, CA 90048, USA
    Cell Transplant 14:411-21. 2005
  8. ncbi Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells
    Run Yu
    UCLA School of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd, Room D3066, Los Angeles, California 90048, USA
    J Endocrinol 191:45-53. 2006
  9. ncbi The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis
    Hongxiang Hui
    Division of Endocrinology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA 90024, USA
    Eur J Cancer 44:160-6. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Hypoglycemic herbs and their action mechanisms
    Hongxiang Hui
    Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, 90073, USA
    Chin Med 4:11. 2009
    ..The efficacy of hypoglycemic herbs is achieved by increasing insulin secretion, enhancing glucose uptake by adipose and muscle tissues, inhibiting glucose absorption from intestine and inhibiting glucose production from heptocytes...
  2. ncbi Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways
    Hongxiang Hui
    UCLA Center of Excellence in Pancreatic Disease, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024 7073, USA
    Pancreas 39:315-22. 2010
    ..That glucagonlike peptide-1 (GLP-1) induces differentiation of primate embryonic stem (ES) cells into insulin-producing cells has been reported by several groups and also confirmed with our observations...
  3. ncbi The role of GLP-1 in the regulation of islet cell mass
    Angela Bulotta
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Cell Biochem Biophys 40:65-78. 2004
    ..The aim of this article is to review those reports that have emphasized the role of GLP-1 as a regulator of islet cell mass as well as its insulin secretory action...
  4. ncbi Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes
    Hongxiang Hui
    Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA
    Diabetes Metab Res Rev 21:313-31. 2005
    ....
  5. ncbi Direct spectrophotometric determination of serum fructose in pancreatic cancer patients
    Hongxiang Hui
    Division of Endocrinology, David Geffen School of Medicine at UCLA, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, CA 90024, USA
    Pancreas 38:706-12. 2009
    ..We sought to develop an assay to measure circulating fructose concentrations in pancreatic cancer patients...
  6. ncbi Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs
    Eugenio D'Amico
    Division of Endocrinology, Cedars Sinai Medical Center, Los Angeles, California, USA
    J Mol Endocrinol 34:377-90. 2005
    ..This report demonstrates that GLP-1 is capable of preserving beta-cell function and protecting cells from apoptotic cell death...
  7. ncbi Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats
    Takeshi Aoki
    Surgical Research, Department of Surgery, Cedars-Sinai Medical Center, David Geffen UCLA School of Medicine, Los Angeles, CA 90048, USA
    Cell Transplant 14:411-21. 2005
    ..e., in a physiological manner)...
  8. ncbi Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells
    Run Yu
    UCLA School of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd, Room D3066, Los Angeles, California 90048, USA
    J Endocrinol 191:45-53. 2006
    ....
  9. ncbi The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis
    Hongxiang Hui
    Division of Endocrinology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA 90024, USA
    Eur J Cancer 44:160-6. 2008
    ..Doxazosin is proposed as a possible novel medical therapy for breast cancer...